Patient Activation for Self-Management of Chronic Conditions (R01, R21 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement is to encourage grant applications that address the influence of patient activation on self-management of chronic conditions.

Although this funding opportunity uses the R01 grant mechanism, it runs in parallel with a program announcement of identical scientific scope: PAR-19-382 for exploratory/developmental (R21) grants.

Deadlines:

  • R01 Due Dates:

    New Applications: June 5, 2020; February 5, 2021; June 5, 2021; February 5, 2022; June 5, 2022; February 5, 2023

    Renewal/Resubmission Applications: March 5, 2021; July 5, 2021; March 5, 2022; July 5, 2022; March 5, 2023

  • R21 Due Dates:

    New Applications- June 16, 2020; February 16, 2021; June 16, 2021; February 16, 2022; June 16, 2022; February 16, 2023

    Resubmissions- March 16, 2021; July 16, 2021; March 16, 2022; July 16, 2022; March 16, 2023 

  • AIDS Due Dates: September 7, 2020; May 7, 2021; September 7, 2021; May 7, 2022; September 7, 2022; May 7, 2023 

PAR-19-381 Expiration Date May 8, 2023  

Eligibility

Faculty

Category

Medical
Medical - Clinical Science

External Deadline

June 5, 2020